-TheWire.in Most technocratic interventions introduced in MGNREGA appear to be designed to aid administrators rather than for actually helping workers. In his 2017-18 Budget speech, finance minister Arun Jaitley asserted with great conviction that the ruling dispensation’s “initiative to geo-tag all MGNREGA assets” to put them “in public domain has established greater transparency”. In 2016-17, the rural development ministry started an initiative called ‘GeoMGNREGA’, under which it was proposed that all assets created under...

-Hindustan Times New Delhi: The government is all set to notify a new set of Right to Information rules that will allow appeals to be withdrawn and, according to activists, put the lives of whistleblowers in danger. The government is all set to notify a new set of Right to Information (RTI) rules that will allow appeals to be withdrawn and, according to activists, put the lives of whistleblowers in danger. The Central...

-The Hindu These VVPAT machines will be manufactured only as per the design approved by the Election Commission. The Election Commission has issued letter of intent for purchase of 16.15 lakh Voter-Verifiable Paper Audit Trail (VVPAT) machines, following a clearance by the Union Cabinet on fund allocations. The machines will be procured in 2017-18 and 2018-19 at an estimated cost of ?3,173.47 crore from public sector undertakings BEL and ECIL. “In its letter sent...

-The Hindu Business Line These bearer instruments can’t make political funding transparent; they don’t address the insidious corporate-politico nexus The Government is all set to introduce a scheme offering political bonds as bearer instruments which will conceal the identity of the bond buyers and enable a process of political donations that, it argues, will make funding political parties transparent. The argument is deeply flawed. Electoral bonds as envisaged here open up yet another...

-The Telegraph New Delhi: Regulatory efforts to get doctors in India to prescribe medicines only through their generic names, initiated about 15 years ago, will need to overcome legal challenges and resistance from sections of doctors and the pharmaceutical industry, experts said. Senior pharmacologists and industry analysts have also said it will be misleading to presume that prescriptions with generic names will automatically translate into lower medicine bills for patients as studies...